Astria Therapeutics Inc. (ATXS)
NASDAQ: ATXS
· Real-Time Price · USD
7.57
0.05 (0.66%)
At close: Oct 06, 2025, 12:57 PM
0.66% (1D)
| Bid | 7.58 |
| Market Cap | 427.21M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -116.92M |
| EPS (ttm) | -2.02 |
| PE Ratio (ttm) | -3.75 |
| Forward PE | -3.43 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 7.59 |
| Volume | 171,873 |
| Avg. Volume (20D) | 362,566.5 |
| Open | 7.58 |
| Previous Close | 7.52 |
| Day's Range | 7.57 - 7.84 |
| 52-Week Range | 3.56 - 12.52 |
| Beta | 0.43 |
| Ex-Dividend Date | n/a |
About ATXS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATXS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATXS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAstria Therapeutics Inc. is scheduled to release its earnings on
Nov 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
+1.65%
ATXS stock has given up its prior loss. Astria The...
Unlock content with
Pro Subscription
2 weeks ago
+1.65%
Astria Therapeutics shares are trading lower. The company announced initial results from the Phase 1a trial of STAR-0310 in healthy subjects.
